Biography
Along with colleagues Pierre Tariot, MD and Eric Reiman, MD, Dr. Langbaum leads the Alzheimer's Preventative Initiative, which is credited with helping launch a new era in Alzheimer’s prevention research. Dr. Langbaum is Director of the Alzheimer's Prevention Registry and its GeneMatch program. Her research is focused on 1) establishing the science of participant recruitment and retention for Alzheimer’s prevention studies studies, including designing and executing participant recruitment registries, 2) assessing the impact of genetic testing and risk disclosure, in particular disclosure of APOE and other biomarker (e.g., brain amyloid) results, and 3) designing and executing preclinical AD treatment studies, including developing sensitive, novel composite cognitive test scores for use as primary endpoint measures. She has published numerous papers on these topics.
Dr. Langbaum serves on several national and international advisory boards. She received her bachelor's degree in neuroscience and psychology with high honors from Oberlin College and her Ph.D. in psychiatric epidemiology from the Johns Hopkins University Bloomberg School of Public Health.